NEW YORK (GenomeWeb) - Biocept reported after the close of the market Thursday that its first quarter revenues increased 47 percent year over year, primarily due to growing commercial test volume.

For the three months ended March 31, the company's total revenues rose to $221,369 from $150,002 the prior year's quarter.

The liquid biopsy firm said it tested 810 billable samples during the first quarter of 2016, up from 289 billable cases during the first quarter of 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.